Smart app to allow patients to manage their side effects independently

Smart app to allow patients to manage their side effects independently

VJOncology

1 year
80 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Managing side effects can be an overwhelming experience for oncology patients, they may be unsure of the severity of their symptoms and could be reluctant to contact their healthcare team. Shereen Nabhani-Gebara, PharmD, BCOP, from Kingston University, London, UK, and her team have developed an app which aims to target this issue. Using this app, patients can look up their symptoms and receive useful information on how to management their symptom and, where necessary, are advised to seek medical attention. Dr Nabhani-Gebara tells us about the positive effect using this app has had on the breast cancer patients so far and believes that it can be effective in other patient groups too. This interview was recorded at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK. Content on www.vjoncology.com from BOPA 2018 is supported by Napp Pharmaceuticals Ltd
Up Next Autoplay
BOPA18__VJO_Rachel Elliott_01
BOPA18__VJO_Rachel Elliott_01
Category: Acute Lymphoblastic Leukemia
0 Views
VJOncology 1 year
New models for patient care: advanced pharmacy practitioners
New models for patient care: advanced pharmacy practitioners
Category: General
820 Views
VJOncology 1 year
Patient symptom and experience trackers
Patient symptom and experience trackers
Category: General
587 Views
VJOncology 1 year
Update from the Scottish Cancer Medicines Outcome Programme
Update from the Scottish Cancer Medicines Outcome Programme
Category: General
581 Views
VJOncology 1 year
The switch to biosimilar rituximab at UCH: 12 months on
The switch to biosimilar rituximab at UCH: 12 months on
Category: Lymphoma
562 Views
VJOncology 1 year
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
Category: General
368 Views
VJOncology 1 year
Visibility of Oncology Pharmacists to patients
Visibility of Oncology Pharmacists to patients
Category: Other
262 Views
VJOncology 1 year
cancer-druginteractions.org: a comprehensive tool for HCPs
cancer-druginteractions.org: a comprehensive tool for HCPs
Category: Other
39 Views
VJOncology 1 year
The emergence of mixed speciality oncology
The emergence of mixed speciality oncology
Category: Other
67 Views
VJOncology 1 year